Navigation Links
The Pittsburgh Life Sciences Greenhouse Congratulates Dr. Paul L. Kornblith, M.D., on Being Named the 2013 recipient of the Schoemaker Award
Date:2/7/2013

PITTSBURGH, Feb. 7, 2013 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to the region's life sciences enterprises, issued this statement through its President and CEO, John W. Manzetti , congratulating PLSG Medical Advisor, Dr. Paul Kornblith on being named the 2013 Pennsylvania Bio Schoemaker Award recipient. Paul L. Kornblith , M.D., is Medical Advisor at the PLSG.

The Hubert J.P. Schoemaker Leadership award recognizes an outstanding leader in the biosciences community who best exemplifies the spirit of innovation in the Commonwealth of Pennsylvania.

"We are thrilled to honor Dr. Paul on receiving this prestigious award and being recognized for his professional achievements," said John W. Manzetti , PLSG President and CEO. "Dr. Paul is a legend and pioneer in our region, and to those of us who know him well, a tireless advocate for life sciences innovation.  His passion and dedication serving the life sciences community to create healthcare solutions for patients is unmatched. He has supported our region exceptionally well, serving on boards of our life sciences companies as director and advisor and as a medical advisor for PLSG." John Manzetti continued, "We are lucky to have him and appreciate all of the ways that he helps us and the region figure out how to create and sustain a burgeoning life sciences industry in western Pennsylvania."

Paul L. Kornblith , M.D., will be honored on March 13, 2013 at the Pennsylvania Bio Annual Dinner celebration at the Pennsylvania Convention Center in Philadelphia.

About the Pittsburgh Life Sciences Greenhouse (PLSG) (www.plsg.com)
The PLSG invests in and supports the growth of biosciences companies in western Pennsylvania. PLSG has a track record of excellence when it comes to attracting and growing life sciences companies in the region. Since its inception in 2001, PLSG has assisted 398 life sciences companies and has helped create or retain nearly 6,000 jobs in western Pennsylvania. 34 companies have been provided with office or laboratory space and 13 have been relocated to Pittsburgh from outside of the region. In addition, the PLSG has invested $18.7 M in 76 companies which has leveraged nearly $900 million in additional capital to the region.


'/>"/>
SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Pittsburgh Based ParentPlus Enters Collaboration with Vitrolife
2. Sangamo BioSciences Announces Fourth Quarter And Full Year 2012 Conference Call And Webcast
3. BioSpace Releases 2013 Life Sciences / Biotech Employment Outlook
4. Caris Life Sciences nimmt Next-Generation Sequencing zur Verbesserung des evidenzbasierten Tumorprofilierungsservices für Krebspatienten auf
5. Caris Life Sciences Adds Next-Generation Sequencing to Enhance Evidence-Based Tumor Profiling Service for Cancer Patients
6. Multi-Axes Cartesian Robotic Platform for Life Sciences Automation
7. Indiana’s Life Sciences Industry Economic Impact Tops $50 billion
8. GlycoCheck Announces Partnership in the United States with Vascular Health Sciences
9. Atharva Lifesciences Consulting Releases the Biggest Ever Compilation of Science Funding Sources for India
10. SeraCare Life Sciences Divests Biorepository Business
11. SeraCare Life Sciences Sharpens Focus on Diagnostics Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® test, ... clinically significant acute bacterial and viral respiratory tract infections by testing the ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... any gene in its endogenous context, enabling overexpression experiments and avoiding the use ... with small RNA guides is transformative for performing systematic gain-of-function studies. , ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
Breaking Biology News(10 mins):